These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17766999)

  • 21. Therapeutic vignette: old and new drugs in mixed connective tissue disease.
    Rozenbaum M; Slobodin G; Boulman N; Feld J; Avshovich N; Ben-Arieh Y; Rosner I
    Isr Med Assoc J; 2008 Nov; 10(11):831-2. PubMed ID: 19070300
    [No Abstract]   [Full Text] [Related]  

  • 22. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic workup for mixed connective tissue disease in childhood.
    Swart JF; Wulffraat NM
    Isr Med Assoc J; 2008; 10(8-9):650-2. PubMed ID: 18847172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined systolic and diastolic heart failure as the first presentation of mixed connective tissue disease.
    Schwagten B; Verheye S; Van den Heuvel P
    Acta Cardiol; 2007 Aug; 62(4):421-3. PubMed ID: 17824306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nailfold capillaroscopy in the evaluation of Raynaud's phenomenon and undifferentiated connective tissue disease].
    Cortes S; Clemente-Coelho P
    Acta Reumatol Port; 2008; 33(2):203-9. PubMed ID: 18604184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute ascites as the onset of mixed connective tissue disease].
    Liñana Santafé JJ; Calvo Catalá J; Hortelano Martínez E; Roig López de los Mozos A; González-Cruz Cervellera I; Herrera Ballester A
    An Med Interna; 1993 Oct; 10(10):504-6. PubMed ID: 8136432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistently low glucose levels despite high-dose methylprednisolone in a woman with mixed connective tissue disease.
    Cumbo-Nacheli G; Torres-Heisecke R; Attallah H
    Eur J Intern Med; 2008 Oct; 19(6):e18-9. PubMed ID: 18848159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sharp syndrome in an infant: a case report].
    Ratovo L; Bérard E; Khaida J; Moupoux F; Cassuto-Viguier E; Mariani R
    Pediatrie; 1992; 47(1):45-6. PubMed ID: 1337776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab treatment in children: comment on the review by Looney et al.
    Bader-Meunier B
    Arthritis Rheum; 2008 Aug; 58(8):2583; author reply 2583-4. PubMed ID: 18668567
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of efficacy of rituximab in Felty's syndrome.
    Sordet C; Gottenberg JE; Hellmich B; Kieffer P; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Feb; 64(2):332-3. PubMed ID: 15647445
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical improvement in antiphospholipid syndrome after rituximab therapy.
    Adamson R; Sangle S; Kaul A; Hughes GR; D'Cruz DP
    J Clin Rheumatol; 2008 Dec; 14(6):359-60. PubMed ID: 19033874
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcinosis cutis of the fingertip associated with Raynaud's phenomenon.
    Yang JH; Kim JW; Park HS; Jang SJ; Choi JC
    J Dermatol; 2006 Dec; 33(12):884-6. PubMed ID: 17169096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.
    Wu YJ; Luo SF; Yang SH; Chen JY; Yu KH; See LC
    Chang Gung Med J; 2008; 31(5):492-502. PubMed ID: 19097597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Klinefelter's syndrome associated with mixed connective tissue disease (Sharp's syndrome) and thrombophilia with postthrombotic syndrome].
    Kasten R; Pfirrmann G; Voigtländer V
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):623-6. PubMed ID: 16033481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.